Migraine

Myofascial trigger points are prevalent in both migraine and tension-type headaches. However, their role in the pathophysiology of each disorder and to what degree is unclear.

The survey of more than 340 women revealed an overwhelming belief that people with migraine are dismissed as exaggerating their symptoms and that employers don't understand the burden of migraine on their employees.

A recent study has found that prolonged auras are common and are phenotypically similar to other auras. Based on the observed duration of aura symptoms, the researchers suggest reconsidering the use of the term “prolonged aura."

Two studies presented at the PAINWeek conference in Las Vegas, Nevada, took a look into the prevalence of acute medication use and overuse among migraineurs, as well as rates of medication discontinuation due to lack of efficacy or side effects.

GammaCore Sapphire, the newest version of gammaCore—a noninvasive vagus nerve stimulator—is now available in the United States to treat patients with migraine and episodic cluster headache.

Approximately 43% of patients using the Migraine Buddy app reported experiencing anxiety and/or depression during at least 1 migraine attack.

Patient with chronic migraine were more likely to have aggression, anger, and hostility. Comorbid aggression may help to identify suicidality in migraine patients.

Building on prior research drawing a link between migraine and fibromyalgia comorbidity, a new study has found that fibromyalgia exacerbates depressive symptoms, migraine intensity, and migraine-related disability.

A recent review evaluated current data on the effects of sex hormones on transient receptor potential channels, which contribute to the sensitization in migraine and chronic pain syndromes.

Despite patients with migraine being younger and having fewer indicators for predicting readmission, they had an increased risk of 30-day hospital readmission due to pain.

The authors of a recent editorial explained that the higher prevalence of migraine in obese individuals may be due to a common etiological factor, because both conditions are linked to inflammatory processes.

PatientPoint and Migraine Again have partnered to provide educational video content in nearly 5000 primary care and obstetrics/gynecology practices nationwide, offering patients and physicians insight into better managing migraine.

While the prevalence of migraine was significantly higher among patients with diabetes, the disease, itself, was not associated with a greater risk of migraine.

Just one-third of respondents of the Migraine in America 2018 survey, conducted by Health Union, are aware of calcitonin gene-related peptide (CGRP) inhibitors. Those who did know about the therapies had questions and concerns, such as cost, insurance coverage, and side effects.